Rivastigmine Tartrate

Product NDC: 63739-577
11-digit product format: 637390577
Labeler code: 63739
Product ID: 63739-577_bd5adccc-d2ca-def8-e053-2a95a90a1843
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Rivastigmine Tartrate
Dosage form: CAPSULE
Route: ORAL
Labeler: McKesson Corporation dba SKY Packaging
Application: ANDA077129
Marketing category: ANDA
Marketing start: 2010-07-01
Marketing end: 2021-04-30
Substance: RIVASTIGMINE TARTRATE
Active strength: 3 mg/1
Pharmacologic classes: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
63739-577-10	2020-07-22	C162847	48780-1	ab0e2407-2d5a-f274-e053-dbdaa90a6471	8dc97a13-c5eb-4421-ae86-7e0877186e2d

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63739-577-10	EA - Each	63739-577	51035149-9cb7-4e13-886a-34a16ecdee0c	1	2013-03-03

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
9IY2357JPE	RIVASTIGMINE TARTRATE	129101-54-8	RIVASTIGMINE TARTRATE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
63739-577-10	63739057710	10 BLISTER PACK in 1 BOX, UNIT-DOSE (63739-577-10) > 10 CAPSULE in 1 BLISTER PACK	10 blister pack	2010-07-01	2021-04-30	No	No	Current